CD274 and neoplasm: Of the patients who had PD-L1 testing on their tumour, 58 (58 of 211, 27%) were PD-L1 negative, 52 (52 of 211, 25%) were PD-L1 1–49%, and 101 (101 of 211, 48%) were PD-L1 ≥ 50%.